Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.720
+0.080 (1.72%)
Nov 21, 2024, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 129 | 303 | 252 | 114 | 192 | 129 | |
| Market Cap Growth | -31.56% | 20.14% | 120.31% | -40.49% | 48.91% | 2.58% | |
| Enterprise Value | 121 | 316 | 247 | 95 | 159 | 114 | |
| Last Close Price | 4.72 | 11.22 | 9.60 | 4.40 | 7.45 | 6.49 | |
| Forward PE | - | 90.85 | - | - | 8.87 | - | |
| PS Ratio | 2.60 | 14.25 | 164.24 | - | 1131.07 | - | |
| PB Ratio | -26.46 | -26.06 | -98.13 | 7.26 | 6.61 | 10.87 | |
| P/TBV Ratio | - | - | - | 7.26 | 6.61 | 10.87 | |
| EV/Sales Ratio | 2.46 | 14.88 | 160.94 | - | 935.98 | - | |
| Debt / Equity Ratio | -6.21 | -2.66 | -9.69 | 0.32 | - | - | |
| Asset Turnover | 1.27 | 0.79 | 0.06 | - | 0.01 | - | |
| Inventory Turnover | 2.22 | 0.92 | - | - | - | - | |
| Quick Ratio | 7.16 | 2.92 | 5.49 | 12.76 | 12.93 | 6.01 | |
| Current Ratio | 7.80 | 3.56 | 5.80 | 13.54 | 13.39 | 6.11 | |
| Return on Equity (ROE) | - | - | -359.22% | -77.36% | -88.46% | -76.99% | |
| Return on Assets (ROA) | 2.70% | -29.67% | -57.21% | -39.99% | -49.07% | -43.84% | |
| Return on Capital (ROIC) | 5.00% | -38.32% | -65.53% | -43.20% | -54.60% | -49.00% | |
| Earnings Yield | -0.88% | -5.30% | -9.41% | -15.16% | -9.42% | -9.89% | |
| FCF Yield | 18.22% | -5.66% | -7.16% | -12.43% | -8.11% | -7.02% | |
| Buyback Yield / Dilution | -2.34% | -1.14% | -1.03% | -9.71% | -19.14% | -5.04% | |
| Total Shareholder Return | -2.34% | -1.14% | -1.03% | -9.71% | -19.14% | -5.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.